Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report?

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

OPK : 1.56 (-1.89%)
OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference

OPKO Health, Inc. (OPK) today announced that Company management will be participating in the 31 Annual Piper Jaffray Healthcare Conference being held December 3-5, 2019 at the Lotte New York Palace in...

OPK : 1.56 (-1.89%)
Opko Health Set to Possibly Pullback After Yesterday's Rally of 1.56%

Opko Health (NASDAQ:OPK) traded in a range yesterday that spanned from a low of $1.61 to a high of $1.64. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $1.63...

OPK : 1.56 (-1.89%)
Novitas Issues Final Local Coverage Determination for the 4Kscore(R) Test

OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore(R) test with defined coverage criteria,...

OPK : 1.56 (-1.89%)
OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat

OPKO Health (OPK) third-quarter results benefit from higher Product revenues and RAYALDEE prescription growth.

TMO : 317.09 (+0.21%)
OPK : 1.56 (-1.89%)
RMD : 148.98 (-0.23%)
EW : 229.16 (-2.19%)
OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -22.22% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

OPK : 1.56 (-1.89%)
OPKO Health: 3Q Earnings Snapshot

MIAMI (AP) _ Opko Health Inc. (OPK) on Tuesday reported a loss of $62 million in its third quarter.

OPK : 1.56 (-1.89%)
OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2019.

OPK : 1.56 (-1.89%)
BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders

BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women's health division, GenPath, today announced the presentation of new research...

OPK : 1.56 (-1.89%)
Earnings Preview: OPKO Health (OPK) Q3 Earnings Expected to Decline

OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OPK : 1.56 (-1.89%)
OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019

OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended September 30, 2019, as well as provide guidance on expected revenues and operating expenses...

OPK : 1.56 (-1.89%)
OPKO Health Enters Oversold Territory

OPKO Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

OPK : 1.56 (-1.89%)
OPKO Health, Inc. Announces Pricing of its Offering of Common Stock

OPKO Health, Inc. ("OPKO Health" or the "Company") (NASDAQ:OPK) today announced the pricing of an underwritten public offering of 50 million shares of its common stock (the "Shares") at a price of $1.50...

OPK : 1.56 (-1.89%)
Implied Volatility Surging for OPKO Health (OPK) Stock Options

Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

OPK : 1.56 (-1.89%)
Enlivex Announces Appointment of New Chief Executive Officer

Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced the appointment of Dr. Oren Hershkovitz as Chief Executive Officer, effective November 16, 2019. Dr. Hershkovitz served...

ENLV : 7.84 (-1.75%)
OPK : 1.56 (-1.89%)
OPKO Health, Inc. Announces Proposed Offering of Common Stock

OPKO Health, Inc. ("OPKO Health" or the "Company") (NASDAQ:OPK) today announced that, subject to market and other conditions, it intends to offer and sell up to $100 million of shares of its common stock...

OPK : 1.56 (-1.89%)
OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

-- Results demonstrated potential to reduce current dosing frequency from once-daily to a single weekly injection --

OPK : 1.56 (-1.89%)
PFE : 38.48 (+0.42%)
OPK November 8th Options Begin Trading

Investors in OPKO Health Inc saw new options begin trading today, for the November 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the...

OPK : 1.56 (-1.89%)
Central Nervous System (CNS) Biomarkers Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022

In this report, the global Central Nervous System (CNS) Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between...

OPK : 1.56 (-1.89%)
PMSNF : 0.0330 (-34.00%)
Is the Options Market Predicting a Spike in OPKO Health (OPK) Stock?

Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

OPK : 1.56 (-1.89%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.88 , AIZ -0.89 , SBAC -2.15 , SO -1.11 , WELL -0.45
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar